Alpha 2.0
Login Register
» Articles » PMID: 9885780

Molecular Genetics of Substance Abuse Vulnerability: a Current Approach

Overview
Journal Neuropsychopharmacology
Date 1999 Jan 14
PMID 9885780
Citations 10
Authors
G R Uhl
Affiliations
Soon will be listed here.
Citing Articles

Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.

Jones J, Luba R, Vogelman J, Comer S Am J Addict. 2015; 25(1):41-8.

PMID: 26692286 PMC: 5444323. DOI: 10.1111/ajad.12316.

A review of pharmacogenetic studies of substance-related disorders.

Jones J, Comer S Drug Alcohol Depend. 2015; 152:1-14.

PMID: 25819021 PMC: 4458176. DOI: 10.1016/j.drugalcdep.2015.03.003.

What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?.

Cumming P, Caprioli D, Dalley J Br J Pharmacol. 2010; 163(8):1586-604.

PMID: 20846139 PMC: 3166689. DOI: 10.1111/j.1476-5381.2010.01036.x.

Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Alcaro A, Huber R, Panksepp J Brain Res Rev. 2007; 56(2):283-321.

PMID: 17905440 PMC: 2238694. DOI: 10.1016/j.brainresrev.2007.07.014.

Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system.

Hatcher J, Richardson J, Guillot T, McCormack A, Di Monte D, Jones D Exp Neurol. 2007; 204(2):619-30.

PMID: 17291500 PMC: 1896133. DOI: 10.1016/j.expneurol.2006.12.020.